Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer

scientific article published on 01 July 2005

Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16080542

P50authorGergely KeszlerQ92277859
Zsolt CsapoQ114092423
P2093author name stringZoltan Papp
Attila Demeter
Andras Jeney
Maria Staub
Istvan Sziller
Julianna Olah
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
P304page(s)2885-2889
P577publication date2005-07-01
P1433published inAnticancer ResearchQ326290
P1476titleMolecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer
P478volume25

Reverse relations

cites work (P2860)
Q34081818CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion
Q80177528Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer
Q37260078EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma
Q36642674Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer
Q41838773Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.
Q36752057Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells
Q37154428Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers
Q34676773Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer
Q39114905Thrombomodulin mediates the progression of epithelial ovarian cancer cells

Search more.